Back
ResMed Vs. Nukkleus Industry Stock Comparison
Sell
42
RMD
ResMed
Last Price:
$237.62
Seasonality Move:
4.35%
Sell
46
NUKK
Nukkleus
Last Price:
$40.15
Seasonality Move:
-21.57%
Sell
42
ResMed (RMD)
is a Sell
Is ResMed a Buy, Sell or Hold?
-
RMD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Nukkleus (NUKK)
is a Sell
Is Nukkleus a Buy, Sell or Hold?
-
NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NUKK Stock Price Chart
RMD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.01 | Sell |
Relative Strength Index (14 RSI): | 45.38 | Sell |
Chaikin Money Flow: | 1840254 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (237.09 - 247.47) | Sell |
Bollinger Bands (100): | (228.48 - 248.96) | Sell |
NUKK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.69 | Buy |
Relative Strength Index (14 RSI): | 77.28 | Buy |
Chaikin Money Flow: | -1366926 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (-7.5 - 22.6) | Buy |
Bollinger Bands (100): | (-4.22 - 11.5) | Buy |
RMD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 238.69 | Sell |
20-day SMA: | 242.98 | Sell |
50-day SMA: | 242.52 | Sell |
200-day SMA: | 219.74 | Buy |
8-day EMA: | 237.82 | Sell |
20-day EMA: | 240.69 | Sell |
50-day EMA: | 240.94 | Sell |
200-day EMA: | 222.98 | Buy |
NUKK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.07 | Buy |
20-day SMA: | 9 | Buy |
50-day SMA: | 4.99 | Buy |
200-day SMA: | 4.78 | Buy |
8-day EMA: | 26.51 | Buy |
20-day EMA: | 14.21 | Buy |
50-day EMA: | 7.47 | Buy |
200-day EMA: | 11.77 | Buy |
ResMed Earnings Growth & RMD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and an increase next year of $1.66 per share.
Nukkleus Earnings Growth & NUKK Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ResMed Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Nukkleus Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |